LifeWatch AG, a developer and provider of medical solutions and remote diagnostic monitoring services to the digital health market, has made a business decision to suspend its current home sleep testing (HST) services “while it explores new innovations and options for providing a more efficient service to its customers and patients,” the company announced in a release.
The release continues, “LifeWatch strongly believes in the value of HST for patients in the cardiovascular space and looks forward to a return to this business in the future. LifeWatch has taken steps to ensure that customers continue to have a provider for home sleep testing and will be informing customers accordingly.”
